A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years

NCT02269475 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1369

Last updated 2017-04-04

Study results available
· View outcomes & findings →

Summary

The study is designed to gather the efficacy, safety and tolerability data in Japanese children 7 to 18 years of age that would support approval of MEDI3250 in Japan.

Conditions

  • Healthy Japanese Children Age 7 Years Through 18 Years

Interventions

DRUG

MEDI3250

MEDI3250

DRUG

Placebo

Placebo

Sponsors & Collaborators

Principal Investigators

  • Masaki Yokohama, MD · Yokohama clinic

  • Toshiko Yamaguchi, MD · Yamaguchi Clinic

  • Haruo Maeta, MD · Maeta Pediatrics Clinic

  • Hideki Nakazawa, MD · HIGASHIKATSUYAMA nakazawa Naika allergy Internal Medicine

  • Atsushi Shibasaki, MD · Shibasaki internal medicine & Pediatrics Clinic

  • Yutaka Igarashi, MD · Igarashi Children's Clinic

  • Keiko Mitamura, MD · Eiju General Hospital

  • Satoshi Yamada, MD · Kyouai Clinic

  • Kiyoshi Niwa, MD · Niwa Family Clinic

  • Ryuta Ono, MD · Kanagawa HImawari Clinic

  • Eiji Kato, MD · Fukuiken Saiseikai Hospital

  • Toshikazu Takahashi, MD · Takahashi Clinic

  • Ryouta Yoshimura, MD · Yoshimura Children's Clinic

  • Hiroshi Taniguchi, MD · Taniguchi Pediatrics Clinic

  • Hidehisa Shinohara, MD · Shinohara Pediatrics Clinic

  • Michiko Tanabe, MD · Tanabe Pediatrics Clinic

  • Haruo Kuroki, MD · Sotobo Children's Clinic

  • Hirokazu Sato, MD · Sunrise Children's Clinic

  • Katsumi Yamada, MD · Yamada Clinic

  • Hiroshi Sakiyama, MD · Sakiyama Pediatric Clinic

  • Hiroji Okawa, MD · Okawa Children & Family Clinic

  • Junichi Ito, MD · Ito ENT Clinic

  • Masato Morimoto, MD · MORIMOTO ENT CLINIC

  • Masakazu Umemoto, MD · Umemoto Pediatric Clinic

  • Tadashi Matuda, MD · Matsuda Pediatrics Clinic

  • Sadayoshi Torigoe, MD · Aquair Medical Station

  • Shigeru Mori, MD · Momotaro Clinic

  • Yutaka Fujimaki, MD · Fujimaki Ent Clinic

  • Masaki Kato, MD · Kato Ear Nose Throat Clinic

  • Hisakuni Sekino, MD · Sekino Hospital

  • Toshikazu Nagakura, MD · Yoga Allergy Clinic

  • Ichiro Ogiwara, MD · Ogiwara Ent Clinic

  • Akitoshi Funato, MD · Medical corporation Seisyuukai Funato Clinic

  • Naohisa Hoshino, MD · Medical corporation Ryoshukai Kanauchi Medical Clinic

  • Munechika Noguchi, MD · Social medical corporation IHL ShinagawaEastOne Medical Clinic

  • Chiaki Noguchi, MD · Shinkoiwa Ekimae Sougou Clinic

  • Kimihiko Yukisada, MD · Yukisada Clinic for internal disease

  • Hiroshi Shimomura, MD · Medical corporation Junyokai Musashino General Clinic

  • Mitsuhiro Nemoto, MD · Nemoto-geka-seikeigeka

  • Naoki Kawai, MD · Kawai Naika Iin

  • Shigehiro Yazima, MD · Yajima Children's Clinic

  • Tetsuhiko Nagao, MD · Midorino Clinic

  • Kenjiro Nakamura, MD · Tenjin Sogo Clinic

  • Wataru Ikematsu, MD · Kobori Building Clinic

  • Shiro Kimura, MD · Kimura Shiro Clinic

  • Mieko Ueda, MD · Ueda Naika Clinic

  • Minako Iwaya, MD · Iwaya Children's Clinic

  • Motohisa Ikeda, MD · Ikeda Naika Clinic

  • Tetsunari Maeda, MD · Sakura Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02269475 on ClinicalTrials.gov